YoVDO

Innovations in First Line Therapy for DLBCL - 7 February 2024

Offered By: Stanford Department of Medicine via YouTube

Tags

Oncology Courses Hematology Courses Clinical Trials Courses Cancer Treatment Courses Cancer Research Courses Targeted Therapy Courses Immunotherapy Courses Lymphomas Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore cutting-edge advancements in first-line therapy for Diffuse Large B-Cell Lymphoma (DLBCL) in this informative Grand Rounds presentation. Led by Dr. Christopher Flowers, Head of the Division of Cancer Medicine and Chair of the Department of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center, the 54-minute talk delves into the latest research and treatment strategies. Gain valuable insights into innovative approaches that are shaping the future of DLBCL management and improving patient outcomes. This presentation, hosted by the Stanford Department of Medicine, offers a unique opportunity to stay abreast of the evolving landscape in lymphoma treatment.

Syllabus

Innovations in First Line Therapy for DLBCL | DoM Grand Rounds | 7 February 2024


Taught by

Stanford Department of Medicine

Related Courses

Practical tips to improve Asian American participation in cancer clinical trials
Stanford University via Coursera Thoracic Oncology
University of Michigan via Coursera Medical Genomics 101
Davidson College via edX Diagnosis and prognosis biomarkers in global health
Institut Pasteur via France Université Numerique Medical Cannabis for Pain Control
Technion - Israel Institute of Technology via Coursera